Financial results of GlaxoSmithKline Pakistan Limited for Quarter ended June 30, 2021

Karachi, GlaxoSmithKline Pakistan Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Karachi on August 23, 2021.

The agenda of the meeting was discussion of profit and loss account for quarter ended June 30, 2021 which portrayed a profit of Rs. 977,497 with earnings per share 3.07 basic and diluted respectively.

Further, nil payment of cash dividend, bonus shares and right shares was agreed.

GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).